Intellia Therapeutics, Inc. · NASDAQ:NTLA

Contrarius Investment Management Ltd reported a 5.50% stake in Intellia Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 12, 2025

Contrarius Investment Management Ltd reported a 5.50% stake in Intellia Therapeutics, Inc., 5,889,936 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G).

Stake
5.50%
Shares
5,889,936
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Contrarius Investment Management Ltd5.50%5,889,936
Contrarius Investment Management (Bermuda) Ltd5.50%5,889,936

Source

View original at SEC

Related